we invited the director of the oncology department at the Ichilov Hospital, Prof. Ido Wolf, to the "Expert Clinic" studio to ask what we must know about cancer today - and what the future holds ...

Ido Wolf, M.D., Head, Oncology Division, Tel Aviv Sourasky Medical Center, Professor of Oncology, Faculty of Medicine, Tel Aviv University, Head, National Israeli Council for Prevention ...

Ido Wolf, director of oncology at Ichilov. “The collaboration with C2i Genomics will provide us a unique opportunity to be world leaders in a field that is definitely one of the most important and ...

The study was conducted and published by a team of researchers led by Dr. Tami Rubinek, Head of the Oncology Research Lab, and Prof. Ido Wolf, MD, Head of Oncology Division, Tel Aviv Medical ...

The study was conducted and published by a team of researchers led by Dr. Tami Rubinek, Head of the Oncology Research Lab, and Prof. Ido Wolf, MD, Head of Oncology Division, Tel Aviv Medical ...

Ido Wolf, MD, head, oncology division, Tel Aviv Sourasky Medical Centre; professor of oncology, faculty of medicine, Tel Aviv University; and head, National Israeli Council for Prevention ...

Preliminary data from ongoing Phase 1/2 trial show dose dependent target engagement and provide clinical proof-of-mechanism for GRWD5769, demonstrating ability to modulate the human ...